Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases... Show more
a developer of pharmaceutical products to treat eye diseases
Industry Biotechnology
A.I.dvisor tells us that KPRX and ABVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KPRX and ABVX's prices will move in lockstep.
| Ticker / NAME | Correlation To KPRX | 1D Price Change % | ||
|---|---|---|---|---|
| KPRX | 100% | +2.71% | ||
| ABVX - KPRX | 31% Poorly correlated | +2.32% | ||
| AKTX - KPRX | 30% Poorly correlated | +3.86% | ||
| MTVA - KPRX | 30% Poorly correlated | -5.14% | ||
| XRTX - KPRX | 30% Poorly correlated | +6.88% | ||
| TCRT - KPRX | 29% Poorly correlated | -1.32% | ||
More | ||||
On September 11, 2026, the Stochastic Oscillator for KPRX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In 60 of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over 85%.
The Moving Average Convergence Divergence (MACD) for KPRX just turned positive on September 11, 2026. Looking at past instances where KPRX's MACD turned positive, the stock continued to rise in 36 of 49 cases over the following month. The odds of a continued upward trend are 73%.
KPRX moved above its 50-day moving average on September 10, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where KPRX advanced for three days, in 187 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 43 of 51 cases where KPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.
The Momentum Indicator moved below the 0 level on August 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on KPRX as a result. In 93 of 100 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The 10-day moving average for KPRX crossed bearishly below the 50-day moving average on September 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where KPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
KPRX broke above its upper Bollinger Band on August 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.696) is normal, around the industry mean (19.994). P/E Ratio (3.670) is within average values for comparable stocks, (27.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.527). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.823) is also within normal values, averaging (427.627).
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. KPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.